about
The molecular basis for oat intolerance in patients with celiac diseaseIdentification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprueEpidemiology of sporadic inclusion body myositis.Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort.Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process.Prevalence, Incidence, and Disease Characteristics of Takayasu Arteritis by Ethnic Background: Data From a Large, Population-Based Cohort Resident in Southern Norway.Primary sequence, together with other factors, influence peptide deimination by peptidylarginine deiminase-4.TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study.Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues.Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease.A gut feeling for joint inflammation - using coeliac disease to understand rheumatoid arthritis.A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study.A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.Comparative analyses of muscle MRI and muscular function in anti-synthetase syndrome patients and matched controls: a cross-sectional studyPrevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature.Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis.Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort.Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts.Interstitial lung disease in systemic sclerosis: progress in screening and early diagnosis.Cardiopulmonary Disease Development in Anti-RNA Polymerase III-positive Systemic Sclerosis: Comparative Analyses from an Unselected, Prospective Patient Cohort.Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum.Takayasu Arteritis and Pregnancy: A Population-Based Study on Outcomes and Mother/Child-Related Concerns.Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.Pulmonary Involvement in the Antisynthetase Syndrome: A Comparative Cross-sectional Study.High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis.Progression and mortality of interstitial lung disease in mixed connective tissue disease: a long-term observational nationwide cohort study.Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease.Endostatin is higher and associated with pulmonary involvement in primary Sjögren's syndrome.Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis.Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease.Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups.
P50
Q21144729-EC5CC1F8-F208-4206-9192-D4976FE92FBEQ24538575-2EA69AE7-73AE-4D4B-ABF3-1F5731A1CCD6Q30248400-F3C77F09-8045-482B-AC86-6F4958E6ED66Q30792028-FC97F870-09DB-4C3C-8EF2-88412AAD4E7BQ31091532-8669F6E6-AED3-4865-9DDE-A5B321BF97CAQ31094021-F847E8BE-B82D-4BD4-BAA0-FD4DDEB17714Q33387898-FBB2C25B-0ACE-484E-B793-500AAE0EC13DQ33706285-81C4456D-C2F4-40E3-8224-72C76DD41563Q34146330-71AFAA93-E8FA-4B62-8136-D0A474DD8AD3Q34218693-CE447D95-288F-49B8-9858-0FC1B20DFB3BQ34501241-D535E158-CACF-4652-9D70-1F701FD02148Q35266391-80D573C5-A7EC-4E8D-B5F4-DF1CD942B3C6Q36001528-A6B93C13-7A9A-40E0-872F-A67CAA4F9B24Q37575470-0D2D7640-E558-40FC-B46E-C11C31445A05Q37604939-F5E43F2D-8E44-4B82-85A6-26C1521FB9B4Q38081345-DA45C949-86B9-4E65-BB0C-506AFF392C0FQ38103534-3A7A4562-E021-4006-BCD0-D18D21DFBFF8Q38550469-500A65AD-A9EC-46BF-A43D-DD05A492D945Q38650368-DAE85305-4F8F-4562-A44A-1DC3A6482414Q38888867-819D6B89-D0BF-4CDE-A205-987401690ED6Q39019351-0653135F-AA4F-408D-9644-11B76D470032Q39021882-3356CD58-B275-40F9-9B51-6707330FB0DFQ39215640-299DBDE4-7B5C-46C2-BB83-5266978BD010Q39456610-EACB31B1-E9BA-451E-B6C4-DC585D2CA1C7Q39871289-80CC6D1E-387F-47C0-AA97-23423D0E5BC4Q39903365-5E2CF998-891C-4959-86D8-A46F2C9EA976Q40263745-0F2490EF-60C2-4305-B160-77142E659B45Q40593651-58C032FE-20FE-4AA4-84C6-0422948D59A7Q40663463-DF0CAB32-D71B-4B96-9C3D-4FD438A0168CQ41009192-F874608C-6410-4035-B9D4-EC030AFB288BQ41293529-98DD8489-9C0B-4906-8C1C-5403C1E90160Q42098903-BDD805F4-3299-49E7-808E-5F2EEEC7E2B7
P50
description
onderzoeker
@nl
name
Øyvind Molberg
@ast
Øyvind Molberg
@en
Øyvind Molberg
@es
Øyvind Molberg
@nl
Øyvind Molberg
@sl
type
label
Øyvind Molberg
@ast
Øyvind Molberg
@en
Øyvind Molberg
@es
Øyvind Molberg
@nl
Øyvind Molberg
@sl
prefLabel
Øyvind Molberg
@ast
Øyvind Molberg
@en
Øyvind Molberg
@es
Øyvind Molberg
@nl
Øyvind Molberg
@sl
P106
P21
P31
P569
2000-01-01T00:00:00Z